216 related articles for article (PubMed ID: 24102369)
21. Combination ALA-PDT and ablative fractional Er:YAG laser (2,940 nm) on the treatment of severe acne.
Yin R; Lin L; Xiao Y; Hao F; Hamblin MR
Lasers Surg Med; 2014 Mar; 46(3):165-72. PubMed ID: 24391075
[TBL] [Abstract][Full Text] [Related]
22. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
Farhi D; Bedane C; Savary J; Basset-Seguin N
Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
[TBL] [Abstract][Full Text] [Related]
23. Short incubation fractional CO
Vrani F; Sotiriou E; Lazaridou E; Vakirlis E; Sideris N; Kirmanidou E; Apalla Z; Lallas A; Ioannides D
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):79-83. PubMed ID: 29869444
[TBL] [Abstract][Full Text] [Related]
24. Ultrasound guided ablative-laser assisted photodynamic therapy of basal cell carcinoma (US-aL-PDT).
Smucler R; Kriz M; Lippert J; Vlk M
Photomed Laser Surg; 2012 Apr; 30(4):200-5. PubMed ID: 22316283
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large-area field cancerization.
Wenande E; Phothong W; Bay C; Karmisholt KE; Haedersdal M; Togsverd-Bo K
Br J Dermatol; 2019 Apr; 180(4):756-764. PubMed ID: 30117140
[TBL] [Abstract][Full Text] [Related]
26. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
27. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.
Horn M; Wolf P; Wulf HC; Warloe T; Fritsch C; Rhodes LE; Kaufmann R; De Rie M; Legat FJ; Stender IM; Solér AM; Wennberg AM; Wong GA; Larkö O
Br J Dermatol; 2003 Dec; 149(6):1242-9. PubMed ID: 14674903
[TBL] [Abstract][Full Text] [Related]
28. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.
Kaufmann R; Spelman L; Weightman W; Reifenberger J; Szeimies RM; Verhaeghe E; Kerrouche N; Sorba V; Villemagne H; Rhodes LE
Br J Dermatol; 2008 May; 158(5):994-9. PubMed ID: 18341663
[TBL] [Abstract][Full Text] [Related]
29. Laser-assisted MAL-PDT associated with acoustic pressure wave ultrasound with short incubation time for field cancerization treatment: A left-right comparison.
Pires MTF; Pereira AD; Durães SMB; Issa MCA; Pires M
Photodiagnosis Photodyn Ther; 2019 Dec; 28():216-220. PubMed ID: 31479804
[TBL] [Abstract][Full Text] [Related]
30. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
Morton CA; Dominicus R; Radny P; Dirschka T; Hauschild A; Reinhold U; Aschoff R; Ulrich M; Keohane S; Ekanayake-Bohlig S; Ibbotson S; Ostendorf R; Berking C; Gröne D; Schulze HJ; Ockenfels HM; Jasnoch V; Kurzen H; Sebastian M; Stege H; Staubach P; Gupta G; Hübinger F; Ziabreva I; Schmitz B; Gertzmann A; Lübbert H; Szeimies RM
Br J Dermatol; 2018 Aug; 179(2):309-319. PubMed ID: 29432644
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.
Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R
Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460
[TBL] [Abstract][Full Text] [Related]
32. Ablative fractional laser-assisted photodynamic therapy vs. ablative fractional laser for oral leukoplakia treatment: A randomized, controlled pilot study.
Yao Y; Shi L; Wang Y; Shen X; Ye S; Tang G; Wu L
Photodiagnosis Photodyn Ther; 2021 Dec; 36():102523. PubMed ID: 34487871
[TBL] [Abstract][Full Text] [Related]
33. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.
Morton C; Campbell S; Gupta G; Keohane S; Lear J; Zaki I; Walton S; Kerrouche N; Thomas G; Soto P;
Br J Dermatol; 2006 Nov; 155(5):1029-36. PubMed ID: 17034536
[TBL] [Abstract][Full Text] [Related]
34. Ablative fractional laser-assisted photodynamic therapy for lentigo maligna: a prospective pilot study.
Räsänen JE; Neittaanmäki N; Jeskanen L; Pölönen I; Snellman E; Grönroos M
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):510-517. PubMed ID: 31465596
[TBL] [Abstract][Full Text] [Related]
35. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Hahn S; Pabst G; Voss D; Foguet M; Schmitz B; Lübbert H; Szeimies RM; ;
Br J Dermatol; 2013 Apr; 168(4):825-36. PubMed ID: 23252768
[TBL] [Abstract][Full Text] [Related]
36. Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in treatment of Bowen's disease: A multicenter randomized controlled trial.
Ahmady S; Nelemans PJ; Kelleners-Smeets NWJ; Arits AHMM; de Rooij MJM; Kessels JPHM; Essers BAB; Mosterd K
J Am Acad Dermatol; 2024 Jan; 90(1):58-65. PubMed ID: 37666424
[TBL] [Abstract][Full Text] [Related]
37. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.
Szeimies RM; Ibbotson S; Murrell DF; Rubel D; Frambach Y; de Berker D; Dummer R; Kerrouche N; Villemagne H;
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1302-11. PubMed ID: 18624836
[TBL] [Abstract][Full Text] [Related]
38. Interventions for basal cell carcinoma of the skin.
Thomson J; Hogan S; Leonardi-Bee J; Williams HC; Bath-Hextall FJ
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003412. PubMed ID: 33202063
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.
Foley P; Freeman M; Menter A; Siller G; El-Azhary RA; Gebauer K; Lowe NJ; Jarratt MT; Murrell DF; Rich P; Pariser DM; Oseroff AR; Barnetson R; Anderson C; Kossard S; Gibson LE; Tope WD
Int J Dermatol; 2009 Nov; 48(11):1236-45. PubMed ID: 20064185
[TBL] [Abstract][Full Text] [Related]
40. Enhanced efficacy of photodynamic therapy after fractional resurfacing: fractional photodynamic rejuvenation.
Ruiz-Rodriguez R; López L; Candelas D; Zelickson B
J Drugs Dermatol; 2007 Aug; 6(8):818-20. PubMed ID: 17763613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
